biotech
Bio-AnalystSupplement research
person

Riboflavin

Migraine and pain

Studies with an unspecified organism reported a change with no confirmed comparison group in migraine headache frequency.

Scope not specified · comparator not confirmed

Publications for this result: 1

Other outcomes and study details

Distinct publications linked to this topic: 5

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.

What has been studied?

Distinct human comparison papers: 0

  • migraine headache frequency

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      General population · Varied across included trials
      Measurement and study conditions
      • Review
      • Systematic review
      • Unknown intervention
      • General population
      • Secondary outcome
      • Study subject not identified
      • Timepoint: Varied across included trials
      • Study comparison: Heterogeneous prior riboflavin trials, including single-entity and combination therapy.

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (2)
  • migraine days per month · Distinct papers needing additional review: 1Evidence criteria check: 1
  • migraine pain · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Migraine and pain

    Related papers 5 · comparison findings need further review

    View selected result
  • Exercise performance

    Related papers 3 · comparison findings need further review

    View results
    • number of ERT stages · Interpretation held
  • Stress and mood

    Related papers 3 · comparison findings need further review

    View results
    • CAT · Interpretation held
    • depression · Comparison details unconfirmed

    More outcome groups: 3

  • Bone, joint, and mobility

    Related papers 2 · human comparison papers 1

    View results
    • BMD · Mixed results · Some studies used more than one ingredient
  • Cognition

    Related papers 2 · comparison findings need further review

    View results
    • cognitive scores · Interpretation held
  • Immune and respiratory health

    Related papers 2 · comparison findings need further review

    View results
    • IL-1β · Interpretation held
    • IL-6 · Interpretation held

    More outcome groups: 2

  • Nutrient status

    Related papers 2 · human comparison papers 1

    View results
    • plasma tHcy · Improvement reported
    • riboflavin · Comparison details unconfirmed
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 13.6 evidence score includes 0 independent human studies and 0 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 130

Papers linked to this topic 5 · distinct papers 5 · comparison findings need further review · papers needing additional review 4

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • migraine days per month: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • migraine headache frequency: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • migraine pain: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Migraine and pain

What the research found

migraine headache frequency

A change was reported, but the comparison could not be confirmed.

Review · Unknown intervention · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

migraine days per month

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

migraine pain

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Observational study · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Exercise performance

What the research found

number of ERT stages

The study needs further checking before its result can be interpreted.

Observational study · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

depression

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

CAT

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · Deficiency group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

MDA

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · Deficiency group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SOD

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · Deficiency group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

T-AOC

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · Deficiency group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Bone, joint, and mobility

What the research found

BMD

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cognition

What the research found

cognitive scores

The study needs further checking before its result can be interpreted.

Observational study · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Animal study · indirect · Unknown intervention · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Immune and respiratory health

What the research found

IL-1β

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

IL-6

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

respiratory sensitiser

The study needs further checking before its result can be interpreted.

Animal study · indirect · Unknown intervention · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TNF-α

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Nutrient status

What the research found

plasma tHcy

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

riboflavin

A change was reported, but the comparison could not be confirmed.

Review · Unknown intervention · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
2
Findings from individual and combined use, plus reviewed cautions
Key precautions
No reviewed caution rules are available yet. Reported caution findings are shown below.
These findings were reported in studies. They do not predict an individual's experience.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

apoptosis1 papers
Riboflavin deficiency is associated with adverse outcomes including growth retardation, increased mortality, liver damage, and apoptosis via mechanisms such as mitochondrial dysfunction, ER stress, ROS, and lipotoxicity.Human studies · Systematic review
adverse events1 papers
Vitamin B2 400 mg/day resulted in significantly fewer side effects (weight gain, dizziness, GI problems) compared to sodium valproate 500 mg/day in migraine patients (p = 0.005).Human studies · Randomized controlled trial